Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
Ther Adv Neurol Disord
; 14: 17562864211039648, 2021.
Article
in En
| MEDLINE
| ID: mdl-34422112
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Ther Adv Neurol Disord
Year:
2021
Document type:
Article
Country of publication: